bioAffinity Technologies, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
bioAffinity Technologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q2 2024.
  • bioAffinity Technologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $287K, a 68.7% increase year-over-year.
  • bioAffinity Technologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $991K, a 123% increase year-over-year.
  • bioAffinity Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $749K, a 201% increase from 2022.
  • bioAffinity Technologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $249K, a 99.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $991K $287K +$117K +68.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $874K $283K +$125K +79.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $749K $235K +$198K +536% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $551K $186K +$107K +136% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $444K $170K +$144K +538% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $300K $158K +$51.6K +48.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $249K $36.8K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $79K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $26.7K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $106K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.